Treatment of the autoimmune and immune-dysregulatory features of patients with STAT1 GOF or STAT3 GOF disease remains challenging. Jakinibs have been used to treat the severe immune-dysregulation in patients with either GOF or GOF mutations.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6322659 | PMC |
http://dx.doi.org/10.1016/j.jaci.2018.07.020 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!